Flu News Friday: The Latest in Influenza Vaccines
September 4, 2020
Burden estimates for the 2019–2020 flu season: 39,000,000–56,000,000 flu illnesses, 18,000,000–26,000,000 flu medical visits, 410,000–740,000 flu hospitalizations, and 24,000–62,000 flu deaths.
Surveillance for COVID-19 is available on COVIDView.
1. US Influenza Vaccine Market (2020–2027) — Growth, Trends, Forecasts
DPI Research, OpenPR / September 3, 2020
2. Protein transduction domain-mediated influenza NP subunit vaccine generates a potent immune response and protection against influenza virus in mice
Yin et al., Emerging Microbes & Infections / September 2, 2020
3. BiondVax: Phase 3 Data for Universal Flu Vaccine in late September to late October 2020
David Bautz, SCR Digest / August 31, 2020
4. Study provides insight on how to build a better flu vaccine
Washington University in St. Louis / August 31, 2020
5. CDC director: Push is on to vaccinate 65% of Americans against flu
Tanya Albert Henry, American Medical Association / August 27, 2020
6. Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope
Kim et al., Virology / August 22, 2020
7. Intraseasonal Influenza Vaccine Effectiveness Waning: Threading the Needle for Immunity
Amandy Roy & Conan Macdougall, Contagion Live / August 21, 2020
8. Why Flu Vaccine Immunity is Short-Lived
Genetic Engineering & Biotechnology News / August 14, 2020
9. Search for universal flu vaccine turns to tobacco plants
Deann Gayman, University of Nebraska-Lincoln Communications / August 7, 2020
Visit Influenzer.org to learn more about our journey to accelerate the development of a universal influenza vaccine. @TheInfluenzers
